Cargando…
Escitalopram—translating molecular properties into clinical benefit: reviewing the evidence in major depression
The majority of currently marketed drugs contain a mixture of enantiomers; however, recent evidence suggests that individual enantiomers can have pharmacological properties that differ importantly from enantiomer mixtures. Escitalopram, the S-enantiomer of citalopram, displays markedly different pha...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2923415/ https://www.ncbi.nlm.nih.gov/pubmed/20147575 http://dx.doi.org/10.1177/0269881109349835 |